U.S. Markets closed

Vir Biotechnology, Inc. (VIR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
31.69-1.96 (-5.82%)
At close: 4:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3141.01
52 Week Low 325.31
50-Day Moving Average 338.14
200-Day Moving Average 344.71

Share Statistics

Avg Vol (3 month) 3954.81k
Avg Vol (10 day) 31.31M
Shares Outstanding 5130.04M
Implied Shares Outstanding 6N/A
Float 865.54M
% Held by Insiders 113.05%
% Held by Institutions 178.59%
Shares Short (Jun 14, 2021) 49.01M
Short Ratio (Jun 14, 2021) 412.49
Short % of Float (Jun 14, 2021) 413.06%
Short % of Shares Outstanding (Jun 14, 2021) 46.93%
Shares Short (prior month May 13, 2021) 48.54M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-450.58%

Management Effectiveness

Return on Assets (ttm)-25.36%
Return on Equity (ttm)-75.70%

Income Statement

Revenue (ttm)72.63M
Revenue Per Share (ttm)0.59
Quarterly Revenue Growth (yoy)-65.40%
Gross Profit (ttm)-196.51M
EBITDA -322.52M
Net Income Avi to Common (ttm)-390.34M
Diluted EPS (ttm)-14.64
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)733.03M
Total Cash Per Share (mrq)5.64
Total Debt (mrq)70.18M
Total Debt/Equity (mrq)10.78
Current Ratio (mrq)2.75
Book Value Per Share (mrq)-23.94

Cash Flow Statement

Operating Cash Flow (ttm)-232.06M
Levered Free Cash Flow (ttm)-98.41M